InvestorsHub Logo
Followers 17
Posts 1701
Boards Moderated 0
Alias Born 03/14/2004

Re: None

Thursday, 06/06/2024 4:45:32 PM

Thursday, June 06, 2024 4:45:32 PM

Post# of 73680
Taking into account the volume and price action today, investors have spoken...the PR has done nothing to garner further interest in the stock. The pps is back at around .007, where it's averaged since May 15th. Maybe the pps would be worse without the PR, who knows. In any event, investors need evidence of a transaction of substance, something positive and material to give investors a reason to invest in this stock. Right now, having the "best antibiotic on the planet" is just hyperbole. Investors need corroboration! "Pfizer announces that Pfizer and Viaderma have entered into a marketing and distribution agreement for Viaderma's flagship product Vitastem... The Agreement provides for substantial milestone payments of __________based on sales 1,000,000 units... Pfizer worldwide director of market distribution is excited about its partnership with Viaderma and looks forward to a long prosperous future".

What will not move the needle IMHO is, "Viaderma has entered into marketing and distribution agreement with a national pharmaceutical company to service broad regions of Western Europe, it is our hope that shipping will begin in early Fall." (Note no specific third party mentioned, nonspecific regions, "hope" of future shipping). That may have excited the faithful in the past, but nothing (yes nothing ever) has come to fruition and investors need more than the same old illusory promises.